SETH SANDESH
SEC insider (Form 3/4/5 filer). CIK 0001566175. Chief Executive Officer at Actinium Pharmaceuticals, Inc. (ATNM). 11 reported Form 4/5 transactions since Sep 2024; latest on Sep 2, 2026. Located in NEW YORK, NY.
Companies SETH SANDESH has filed insider reports for
- Actinium Pharmaceuticals, Inc. (ATNM): Director, Officer, Chief Executive Officer
SETH SANDESH
CIK: 0001566175
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Actinium Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Sep 2, 2026ATNM
Actinium Pharmaceuticals, Inc.
AwardDirect753.6K shares- - Sep 2, 2026ATNM
Actinium Pharmaceuticals, Inc.
AwardDirect1M shares- - Aug 18, 2025ATNM
Actinium Pharmaceuticals, Inc.
Tax PaymentDirect120.9K shares at avg. $1.71$207K - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
16.7K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
25K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
33.3K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
50K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
139.1K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
310.2K shares- - Mar 31, 2025ATNM
Actinium Pharmaceuticals, Inc.
DispositionDirectStock Option (Right to Buy)
827.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | Award | 753,600 | - | $0 | Direct |
| Sep 2, 2026 | ATNM Actinium Pharmaceuticals, Inc. | Award | 1,027,274 | - | $0 | Direct |
| Aug 18, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Tax Payment | 120,900 | $1.71 | $206,739 | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 16,666 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 25,000 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 33,333 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 139,062 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 310,182 | - | - | Direct |
| Mar 31, 2025 | ATNM Actinium Pharmaceuticals, Inc. | Disposition Stock Option (Right to Buy) | 827,366 | - | - | Direct |
1-10 of 11 transactions